Growth Metrics

Journey Medical (DERM) Leases (2020 - 2026)

Journey Medical filings provide 6 years of Leases readings, the most recent being $111000.0 for Q4 2025.

  • On a quarterly basis, Leases fell 44.22% to $111000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $111000.0, a 44.22% decrease, with the full-year FY2025 number at $111000.0, down 44.22% from a year prior.
  • Leases hit $111000.0 in Q4 2025 for Journey Medical, down from $134000.0 in the prior quarter.
  • In the past five years, Leases ranged from a high of $199000.0 in Q4 2024 to a low of $22000.0 in Q3 2022.
  • Median Leases over the past 5 years was $111000.0 (2021), compared with a mean of $111388.9.
  • Biggest five-year swings in Leases: plummeted 80.18% in 2022 and later surged 463.64% in 2023.
  • Journey Medical's Leases stood at $89000.0 in 2021, then skyrocketed by 112.36% to $189000.0 in 2022, then tumbled by 46.56% to $101000.0 in 2023, then surged by 97.03% to $199000.0 in 2024, then crashed by 44.22% to $111000.0 in 2025.
  • The last three reported values for Leases were $111000.0 (Q4 2025), $134000.0 (Q3 2025), and $156000.0 (Q2 2025) per Business Quant data.